CATALYST PHARMACEUTICALS, INC.
Biopharmaceutical company commercializing drugs for rare neurological and autoimmune diseases.
CPRX | US
Overview
Corporate Details
- ISIN(s):
- US14888U1016
- LEI:
- Country:
- United States of America
- Address:
- 355 ALHAMBRA CIRCLE, 33134 CORAL GABLES
- Website:
- https://catalystpharma.com/
- Sector:
- Manufacturing
Description
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing prescription drugs for rare diseases. The company is dedicated to improving the lives of patients with underserved medical conditions, particularly in the fields of neurology and epilepsy. Its portfolio includes therapies for rare autoimmune disorders such as Lambert-Eaton myasthenic syndrome (LEMS). The company also markets FYCOMPA (perampanel), a medication used to treat partial-onset seizures.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CATALYST PHARMACEUTICALS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CATALYST PHARMACEUTICALS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CATALYST PHARMACEUTICALS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
